Makkah – Corporate Communications

King Abdullah Medical City – a member of the Makkah Health Cluster – has announced the launch of the first comprehensive program at the Ministry of Health level to integrate Lipoprotein(a) – Lp(a) testing into the cardiovascular risk assessment framework. This initiative supports the advancement of preventive services for patients with atherosclerotic cardiovascular disease (ASCVD).

The medical city stated that the program includes a fully integrated assessment system, beginning with a comprehensive clinical evaluation covering symptoms, physical examination, associated risk factors, and lifestyle patterns. It also incorporates detailed personal and family medical history, with a focus on premature cardiovascular disease and inherited lipid disorders.

The program further includes advanced laboratory investigations such as total cholesterol, triglycerides, high-density lipoprotein (HDL), non-HDL cholesterol, and—when indicated—atherogenic particle markers. In addition, supportive imaging and diagnostic tools are utilized to enhance risk stratification accuracy and optimize therapeutic decision-making.

This framework is supported by specialized Dyslipidaemia Clinics, offering structured evaluation and genetic testing for suspected cases, thereby strengthening early and precise diagnosis for high-risk populations.

KAMC emphasized that incorporating Lp(a)—a genetically determined risk factor that may not be clearly identified through conventional lipid testing—significantly improves risk classification, enables early identification of individuals at highest risk, and enhances preventive treatment strategies using the latest lipid-lowering therapies to achieve therapeutic targets more efficiently.

The launch of this program reflects KAMC’s commitment to advancing proactive prevention, elevating the quality of cardiac care, reducing the incidence of heart attacks and strokes, and improving patients’ quality of life, in alignment with the goals of Saudi Arabia’s healthcare transformation and Vision 2030.